Researchers utilize TCGA data to identify biomarkers for early detection and prognosis of cancer. They also use it to study the molecular mechanisms underlying cancer progression and resistance to therapy. The data aids in the development of personalized medicine approaches by identifying specific genetic alterations in individual tumors.
